Arbutus Biopharma shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Arbutus Biopharma (ABUS) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Arbutus Biopharma
Tip: Access up to 7 years of quarterly data
All positions including Arbutus Biopharma held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Arbutus Biopharma by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $9.9M | 2.2M | 4.54 |
| 2025-03-31 | $7.2M | 2.1M | 3.49 |
| 2024-12-31 | $1.7M | 532k | 3.27 |
| 2024-09-30 | $2.2M | 560k | 3.85 |
| 2024-06-30 | $486k | 157k | 3.09 |
| 2024-03-31 | $451k | 175k | 2.58 |
| 2023-12-31 | $317k | 127k | 2.50 |
| 2023-09-30 | $415k | 205k | 2.03 |
| 2023-06-30 | $511k | 222k | 2.30 |
| 2023-03-31 | $820k | 271k | 3.03 |
| 2022-12-31 | $895k | 384k | 2.33 |
| 2022-06-30 | $2.0M | 731k | 2.71 |
| 2022-03-31 | $4.6M | 1.5M | 2.98 |
| 2021-12-31 | $2.7M | 693k | 3.89 |
| 2021-09-30 | $1.2M | 287k | 4.29 |
| 2021-03-31 | $149k | 45k | 3.34 |
| 2020-12-31 | $210k | 59k | 3.54 |
| 2020-09-30 | $795k | 254k | 3.13 |
| 2020-06-30 | $3.0M | 1.7M | 1.82 |
| 2019-12-31 | $239k | 86k | 2.78 |
| 2019-09-30 | $160k | 104k | 1.53 |
| 2019-06-30 | $418k | 201k | 2.08 |
| 2019-03-31 | $790k | 221k | 3.58 |
| 2018-12-31 | $335k | 87k | 3.83 |
| 2018-09-30 | $856k | 91k | 9.45 |
| 2018-06-30 | $2.6M | 353k | 7.30 |
| 2018-03-31 | $533k | 107k | 5.00 |
| 2017-12-31 | $275k | 55k | 5.04 |
| 2017-06-30 | $330k | 92k | 3.60 |
| 2017-03-31 | $785k | 242k | 3.25 |
| 2016-12-31 | $892k | 364k | 2.45 |
| 2016-09-30 | $2.1M | 610k | 3.44 |
| 2016-06-30 | $2.4M | 681k | 3.48 |
| 2016-03-31 | $3.1M | 749k | 4.13 |
| 2015-12-31 | $3.0M | 675k | 4.45 |
| 2015-09-30 | $4.3M | 705k | 6.09 |